According to the latest reports, it seems that the US FDA is seeking ways to persuade a federal court in order to dismiss a lawsuit that’s challenging the repeated advisories against using ivermectin to treat COVID-19 cases. Check out the latest reports about the matter below.
FDA prepares to get rid of ivermectin caseu
The U.S. Food and Drug Administration (FDA) has requested a federal court to dismiss a lawsuit that challenges its repeated advisories against using ivermectin to treat COVID-19.
Three doctors had filed the lawsuit alleging that the FDA’s warnings were illegal. The FDA has filed a sealed motion requesting the dismissal of the case in the U.S. District Court for the Southern District of Texas.
The late 2023 motion was sealed because the exhibits cited by the government “include confidential information” from another legal proceeding.
The government has stated that it will file redacted versions of the motion for public perusal, but it has not yet done so. On Jan. 12, attorneys for the doctors urged the court to reject the government’s latest attempt to dismiss the case.
“The FDA exceeded its authority by repeatedly issuing public directives not to use ivermectin for COVID-19, even though the drug remains fully approved for human use,” they wrote.
One of the directives said: “You are not a horse. Stop it with the #Ivermectin. It’s not authorized for treating #COVID.”
It is also important to mention the fact that the government motion came after an appeals court found that the FDA likely overstepped its authority with the warnings.
“FDA can inform, but it has identified no authority allowing it to recommend consumers ’stop’ taking medicine,” U.S. Circuit Judge Don Willett, an appointee of then-President Donald Trump, wrote in the ruling.
The case was sent back to U.S. District Judge Jeffrey Brown by the appeals court. In 2022, Judge Brown stated that the doctors were unable to prove their allegations.
The FDA filed a sealed motion with Judge Brown, who was appointed by President Trump, requesting that he dismiss the case. The doctors’ lawyers claim that the FDA’s motion argues that the plaintiffs did not suffer injuries that can be traced back to the FDA, and that a ruling in favor of the plaintiffs cannot remedy the situation.
“The FDA is wrong,” the lawyers said.
They continued and said the following: “Plaintiffs have suffered interference with their practice of medicine and the doctor-patient relationship, economic harm, reputational harm, and increased exposure to malpractice liability, and have been subject to disciplinary proceedings and forced resignations, all of which clearly trace to the FDA’s campaign against ivermectin and would be remedied by equitable relief.”
